crystal structure inhibitor-bound human -lipoxygenase-activating protein 
leukotrienes proinflammatory products arachidonic acid oxidation -lipoxygenase shown involved respiratory cardiovascular diseases integral membrane protein flap essential leukotriene biosynthesis describe x-ray crystal structures human flap complex two leukotriene biosynthesis inhibitors angstrom resolution respectively structures show inhibitors bind membrane-embedded pockets flap suggests inhibitors prevent arachidonic acid binding flap subsequently transferred -lipoxygenase thereby preventing leukotriene biosynthesis structural information provides platform development therapeutics respiratory cardiovascular diseases 
